Literature DB >> 6968215

Enhanced in vitro synthesis of IgM rheumatoid factor in rheumatoid arthritis.

W J Koopman, R E Schrohenloher.   

Abstract

Peripheral blood mononuclear leukocytes (MNL) from 42 patients with classic/definite seropositive rheumatoid arthritis (RA) and 24 healthy adult controls were tested for their capacity to produce IgM rheumatoid factor (RF) in vitro in the presence and absence of pokeweed mitogen (PWM). In no instance was spontaneous elaboration of IgM RF from control MNL observed. In contrast, MNL from 16 of the 42 RA patients spontaneously synthesized IgM RF (22 +/- 43 ng/culture) which constituted a substantial fraction of the total IgM in these culture fluids (48 +/- 26%). Pokeweed mitogen induced detectable quantities of IgM RF in MNL culture supernatants from 10 of 24 controls (12 +/- 11 ng/culture) and 33 of 42 RA patients (60 +/- 82 ng/culture, P = 0.008). IgM RF constituted a significantly higher proportion of the total IgM in RA MNL supernatants than in control supernatants (11 +/- 11% versus 1.01 +/- 1.03%; P = 0.013). IgM RF production (spontaneous and PWM-induced) was dependent upon de novo protein synthesis. The results indicate that B cells programmed to produce IgM RF are present in both normal and RA B cell repertoires, but are preferentially expressed in RA.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6968215     DOI: 10.1002/art.1780230904

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  18 in total

1.  Production of IgM rheumatoid factor by normal lymphocytes after stimulation with preparations containing IgM rheumatoid factor from patients with juvenile arthritis.

Authors:  G Nesher; T L Moore; T G Osborn; R W Dorner
Journal:  Ann Rheum Dis       Date:  1991-03       Impact factor: 19.103

2.  Regulation of human immunoglobulin production in vitro by prostaglandin E2.

Authors:  N D Staite; G S Panayi
Journal:  Clin Exp Immunol       Date:  1982-07       Impact factor: 4.330

3.  Enhanced in vitro IgM rheumatoid factor synthesis in seropositive rheumatoid arthritis families.

Authors:  G S Alarcón; B O Barger; R C Go; R T Acton; R E Schrohenloher; W J Koopman
Journal:  Rheumatol Int       Date:  1987       Impact factor: 2.631

4.  Enhanced T helper cell function for the spontaneous production of IgM rheumatoid factor in vitro in rheumatoid arthritis.

Authors:  V Patel; G S Panayi
Journal:  Clin Exp Immunol       Date:  1984-06       Impact factor: 4.330

5.  Indomethacin inhibits in vitro immunoglobulin production by human B-lymphocytes.

Authors:  G S Panayi; N D Staite; A Unger
Journal:  Agents Actions       Date:  1981-12

6.  Cellular localization of rheumatoid factor idiotypes.

Authors:  V R Bonagura; H G Kunkel; B Pernis
Journal:  J Clin Invest       Date:  1982-06       Impact factor: 14.808

7.  Correlative studies of rheumatoid factors and anti-viral antibodies in patients with rheumatoid arthritis.

Authors:  A S Ferraro; M M Newkirk
Journal:  Clin Exp Immunol       Date:  1993-06       Impact factor: 4.330

8.  In vitro synthesis of immunoglobulins and IgM-rheumatoid factor by blood mononuclear cells of patients with rheumatoid arthritis.

Authors:  N Olsen; M Ziff; H E Jasin
Journal:  Rheumatol Int       Date:  1982       Impact factor: 2.631

9.  In vitro immunoglobulin synthesis by lymphocytes from patients with rheumatoid arthritis. I. Effect of monocyte depletion and demonstration of an increased proportion of lymphocytes forming rosettes with mouse erythrocytes.

Authors:  C Plater-Zyberk; M F Clarke; K Lam; P A Mumford; G R Room; R N Maini
Journal:  Clin Exp Immunol       Date:  1983-06       Impact factor: 4.330

10.  Peripheral T lymphocytes from rheumatoid arthritis patients recognize determinants on light chains and/or Fab fragments of immunoglobulin G.

Authors:  N Radoiu; R P Cleveland; M A Leon
Journal:  J Clin Invest       Date:  1982-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.